Hong Zheng Mingming Yuan Huanwen Wu Rongrong Chen Yunong Gao
10.3389/fmed.2020.581982
Front Med (Lausanne)
2020 Nov 3;7:581982.
double germline mutations mixed serous-endometrioid endometrial carcinoma next-generation sequencing tislelizumab tumor heterogeneity
CC BY
https://pubmed.ncbi.nlm.nih.gov/33224963/
Case Reports
PMC7670051
33224963
Case Report: Double Germline Mutations in BRCA1 and MSH2 in a Patient With Mixed Serous-Endometrioid Endometrial Carcinoma
2020